Specialty Portfolio

Human Vaccines &
Biologicals.

A dedicated enquiry pathway for human vaccines, biological products and related healthcare requirements. Product-level availability, documentation and destination-market eligibility are confirmed case by case.

Focused sourcing

Built around the requirements of each market.

Times Medicament’s website portfolio includes a dedicated pathway for human vaccines and biologicals. Because the supplied human product list does not identify a separate vaccine/biological category for each individual product, this page intentionally avoids assigning products to this section without source support.

For a specific molecule, brand, manufacturer or market requirement, send the details to our export team and we can review the appropriate supply route.

Specialty access

Three focused enquiry pathways.

01

Human Vaccines

Vaccines for human healthcare requirements, subject to registration, cold-chain, documentation and destination-market conditions.

Enquire →
02

Biological Products

Source-supported enquiries for biological products and specialist therapies, with product-level confirmation before quotation.

Enquire →
03

Monoclonal Antibodies

Specialty biologics enquiries with attention to product specifications, documentation and market requirements.

Enquire →
Specialty products.
Responsible access.
Start a Conversation

Have a specific vaccine or biological requirement?

Share the product, destination country and quantity. Our team will review the requirement and revert with the appropriate next steps.

Request a Quote →